<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Basic Res Cardiol. 2013 September ; 108(5): 378. doi:10.1007/s00395-013-0378-5. <br />  <br />  <br />  <br />                            Stanniocalcin1 key mediator amyloidogenic light chain <br />                            induced cardiotoxicity <br />                            Jian Guan1,2, Shikha Mishra1, Jianru Shi1, Eva Plovie1, Yiling Qiu1, Xin Cao1, Davide <br />                            Gianni3, Bingbing Jiang1, Federica del Monte4, Lawreen H. Connors5, David C. Seldin5, <br />                            Francesca Lavatelli6, Paola Rognoni6, Giovanni Palladini6, Giampaolo Merlini6, Rodney H. <br />                            Falk7, Marc J. Semigran8, G. William Dec Jr.8, Calum  MacRae1, Ronglih Liao1,7 <br />                            1Cardiovascular Division, Brigham Women&apos;s Hospital, Harvard Medical School, Boston,  <br />                            2Molecular    Medicine Graduate Program, Boston University School Medicine, Boston,                            3University   Massachusetts Medical School, Worcester,                            4Cardiovascular      Institute, Beth Israel Deaconess Medical Center, Boston, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            5Amyloid    Research Treatment Program, Boston University School Medicine, Boston,                            6Amyloid    Research Treatment Center, University Pavia, Pavia, Italy <br />                            7Cardiac    Amyloidosis Program, Cardiovascular Division, Brigham Women&apos;s Hospital Boston, <br />                                                       8Harvard    Medical School, Boston MA Heart Center, Massachusetts General Hospital, Boston,  <br />                            Abstract <br />                                 Immunoglobulin light chain (LC) amyloidosis (AL) results overproduction circulating <br />                                 amyloidogenic LC proteins subsequent amyloid fibril deposition organs. Mortality AL <br />                                 amyloidosis patients highly associated rapidly progressive AL cardiomyopathy, marked <br />                                 profound impairment diastolic systolic cardiac function significant early mortality. <br />                                 myocardial fibril deposition contributes severe diastolic dysfunction seen AL <br />                                 cardiomyopathy patients, degree fibril deposition correlate                                 prognosis. Previously, showed direct cardiotoxic effect amyloidogenic LC <br />                                 proteins (AL-LC), contribute pathophysiology mortality observed AL <br />                                 cardiomyopathy patients.  mechanisms underlying AL-LC related cardiotoxicity <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 remain unknown. Mammalian stanniocalcin1 (STC1) associated number cellular <br />                                 processes including oxidative stress cell death.  STC1 expression                                 elevated cardiac tissue AL cardiomyopathy patients, induced isolated <br />                                 cardiomyocytes response AL-LC, non-amyloidogenic LC. STC1 overexpression                                 vitro recapitulates pathophysiology AL-LC mediated cardiotoxicity, increased ROS <br />                                 production, contractile dysfunction cell death. Overexpression STC1 vivo results                                 significant cardiac dysfunction cell death. Genetic silencing STC1 prevents AL-LC induced <br />                                 cardiotoxicity cardiomyocytes protects AL-LC induced cell death early <br />                                 mortality zebrafish. cardiotoxic effects STC1 appears mediated mitochondrial <br />                                 dysfunction indicated loss mitochondrial membrane potential, ROS production  <br />  <br />  <br />  <br />                            Correspondence Dr. Ronglih Liao, Cardiac Muscle Research Laboratory, Cardiovascular Division, Brigham Women&apos;s Hospital, <br />                            Harvard Medical School, Boston, MA 02115, USA, rliao@rics.bwh.harvard.edu, Tele: 617-525-4864 (R.L.), Fax: 617-525-4868 <br />                            (R.L.). <br />                            Conflict  authors declare conflict  <br />                             Guan et al.                                                                                                   Page 2 <br />  <br />  <br />                                     increased mitochondrial calcium levels. Collectively, work identifies STC1 critical <br />                                     determinant AL-LC cardiotoxicity. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Keywords <br />                                     Amyloidosis; Cardiomyopathy; cardiac toxicity <br />  <br />                                               &#226;&#8364;&#732;Amyloidoses&#226;&#8364;&#8482; represent group diseases characterized extracellular deposition                                               amyloid fibrils various tissues body [25]. Light chain (AL) amyloidosis                                               common systemic amyloidosis Europe consequence plasma cell <br />                                               dyscrasia monoclonal overproduction amyloidogenic immunoglobulin light chain <br />                                               (LC) proteins associated deposition amyloid fibrils multiple tissues [26].                                               half AL amyloidosis patients cardiac involvement, presenting rapidly <br />                                               progressive amyloid cardiomyopathy [10, 14]. Currently, limited therapies <br />                                               available AL amyloid cardiomyopathy, requiring cardiac transplantation,                                               median survival comparable malignant cancers [7]. Little                                               known regarding mechanisms underlie pathogenesis AL cardiomyopathy. <br />                                               Patients AL cardiomyopathy unresponsive traditional heart failure regimens <br />                                               suggesting distinct, unknown mechanisms contribute pathogenesis AL <br />                                               cardiomyopathy.  great need uncover essential modulators AL <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               cardiomyopathy identify novel therapeutic targets. <br />  <br />                                               Interstitial amyloid fibril deposition heart long thought basis                                               pathogenesis AL cardiomyopathy. Clinical observations,  suggested                                               important discrepancy survival cardiac amyloidosis patients similar degrees <br />                                               cardiac fibril infiltration, varying amyloid precursor proteins, suggesting alternative <br />                                               biological mechanisms disease progression. addition, reduction circulating light <br />                                               chain levels, cardiac amyloid fibril deposition, associated improved patient <br />                                               outcomes [8]. notion amyloid precursor proteins contribute disease pathology                                               equal extent amyloid fibril deposition suggested amyloid disease <br />                                               states [43].  previous studies provided evidence direct, intrinsic <br />                                               cardiotoxic effect amyloidogenic light chain (AL-LC) proteins isolated <br />                                               cardiomyocytes intact mouse hearts, suggesting AL-LC cardiotoxicity                                               contribute cardiac dysfunction observed AL cardiomyopathy absence                                               fibril deposition [2, 24]. recent work implicated non-canonical TAB1 (TAK1 <br />                                               binding protein 1)-mediated p38MAPK autophosphorylation key modulator AL-LC <br />                                               cardiac toxicity [34]. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Unbiased gene expression analysis human hearts explanted patients AL <br />                                               cardiomyopathy indicated increased differential expression Stanniocalcin1 (STC1) <br />                                               (personal communication, F. del Monte). STC1 originally identified corpuscles                                               Stannius fish secreted Ca2+ regulatory hormone [15] mammalian STC1                                               associated number cellular processes including oxidative stress, inflammation, cell <br />                                               death impaired calcium homeostasis, implicated                                               pathogenesis AL-LC induced cardiotoxicity [20, 21, 30, 33]. set                                               determine role STC1 pathophysiology AL-LC cardiotoxicity                                               potential relationship p38MAPK activation. <br />  <br />                                                demonstrate upregulation STC1 heart tissue AL amyloid <br />                                               cardiomyopathy patients, isolated rat cardiomyocytes exposed human AL-LC <br />                                               proteins, p38MAPK dependent manner. STC1 provokes mitochondrial dysfunction <br />                                               leading excessive ROS production important mediating AL amyloid <br />  <br />  <br />                                                Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                           Page 3 <br />  <br />  <br />                                             cardiotoxicity cellular vivo models, overexpression STC1 <br />                                             recapitulating cellular dysfunction associated human AL-LC exposure vitro <br />                                             vivo.  genetic silencing STC1 protected AL-LC cardiotoxicity <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             early death cellular zebrafish models. <br />  <br />                               Methods <br />                               Human tissues <br />                                             procedures related human tissue reviewed approved Institution <br />                                             Review Board (IRB) Boston University School Medicine Massachusetts General <br />                                             Hospital. Bence-Jones proteins, (AL-LC, amyloidogenic LC isolated AL amyloid <br />                                             patients LC, non-amyloidogenic LC isolated non-amyloidosis multiple <br />                                             myeloma patients), purified urine collection collaboration Boston <br />                                             University Amyloid Treatment Research Program [5]. purity fractionated LC <br />                                             proteins assessed SDS-PAGE immunoblotting described previously [2]. <br />                                             Additional information regarding human LC protein included Table S1. Human heart <br />                                             tissues collected explanted hearts patients AL amyloid cardiomyopathy                                             Massachusetts General Hospital. Non-disease control human hearts obtained                                             National Disease Research Interchange. Additional information regarding human <br />                                             samples included Table S2. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Animal care <br />                                             animal (mouse, rat zebrafish) procedures usages reviewed approved <br />                                             Institutional Animal Care Use Committee Harvard Medical School. Animals <br />                                             housed Association Assessment Accreditation Laboratory Animal Care <br />                                             (AAALC) accredited animal care facilities 12 hour light-dark cycle fed <br />                                             laboratory chow ad libidum. Rats cardiomyocytes isolation purchased                                             Charles River Laboratory (male Wistar rats, 150-200g, catalog #003). Mice purchased <br />                                             Jackson Laboratory (female FVB/NJ/mice 10weeks catalog #001800). Wild type <br />                                             zebrafish purchased Ekkwill Waterlife Resources (Ruskin). Care breeding                                             zebrafish performed described previously [32, 41]. <br />  <br />                               Chemicals reagents <br />                                             General chemicals reagents obtained Sigma unless specified. Low glucose <br />                                             DMEM, TMRE, Rhod-2, Mitotracker-Green Laminin acquired Invitrogen. <br />                                             Mito-tempo Santa Cruz Biotechnology. Trypsin Collagenase purchased <br />                                             Willington. SB203580 compound obtained Calbiochem. Antibodies                                             obtained Santa Cruz Biotechnology (STC1, Bax, Bcl-2), Cell signaling <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Technology (p38MAPK phosphorylated p38MAPK), Sigma (ACTININ), R<span id='am-6' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amp</span>;D Systems <br />                                             (STC1, GAPDH) Developmental Studies Hybridoma Bank (MF20). Secondary antibodies <br />                                             immunohistochemistry (Donkey anti-goat antibody-Alexa Fluo 555, Goat anti-rabbit <br />                                             antibody- Alexa Fluo 488, Goat anti-mouse antibody- Alexa Fluo 647)                                             Invitrogen. Adenovirus expressing kit, adenovirus purification kit, STC1 recombinant <br />                                             protein purchased Stratagene, Adenopure, Biovendor, respectively. <br />  <br />                               Adenovirus preparation STC1 overexpression knockdown isolated <br />                               cardiomyocytes <br />                                             length murine STC1 cDNA (Open Biosystems), subcloned pShuttle-IRES- <br />                                             GFP vector (Adeasy adenovirus  Stratagene), later used generate adenovirus <br />                                             HEK cells according manufacturer&apos;s instruction. Control GFP adenovirus                                             generated using approach. prepare STC1 shRNA adenovirus, expression <br />  <br />  <br />                                              Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                            Page 4 <br />  <br />  <br />                                           cassette containing shRNA cloning site, U6 promoter pCMV promoter driven GFP <br />                                           obtained pSicoR-GFP vector (Addgene) pShuttle vector. shRNA <br />                                           oligonucleotides (GATTC TCCCT CACAC ATCA) targeting STC1 designed using <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Invitrogen online software. scrambled shRNA oligonucleotides (GACCC ACTAT <br />                                           CTAAC CTCT) STC1 shRNA designed using siRNA Wizard software <br />                                           (InvivoGen). Adenovirus purified Adenopure kit Puresyn  <br />  <br />                               Cardiomyocytes isolation culture <br />                                           Adult rat ventricular cardiomyocytes isolated male Wistar rats using                                           collagenase-based enzymatic digestion method previously described [16]. <br />                                           Cardiomyocytes treated vehicle (ultrapure water), 20 &#206;&#188;g/mL LC AL- <br />                                           LC designated time points described Results section. Neonatal rat <br />                                           cardiomyocytes isolated 1-2 day olds Wistar rats (Charles River Laboratory <br />                                           #003) previous described [13]. <br />  <br />                               Cell contractility intracellular Ca2+ measurements <br />                                           Cellular function Ca2+ homeostasis measured cultured adult ventricular <br />                                           cardiomyocytes using video edge detection fluorescence measurements calcium <br />                                           sensitive dye, Fura-2, respectively described previously [2]. Briefly, cardiomyocytes                                           infected Adeno-STC1 Adeno-GFP virus, treated vehicle, LC NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           AL-LC 24 hours. Cardiomyocytes perfused 1.2 mmol/L Ca2+ Tyrode&apos;s <br />                                           buffer 37&#194;&#176;C pacing 5 Hz. Percentage cellular shortening calculated                                           ratio difference systolic diastolic cell length diastolic cell length. <br />                                           Calcium amplitude calculated difference systolic diastolic cellular <br />                                           calcium levels (ratio F360/380). 4-6 cells measured biological replicate 3 <br />                                           biological replicates performed grouped statistical analysis. <br />  <br />                               Cell death assay <br />                                           designed time points, cultured cardiomyocytes washed PBS,                                           immediately fixed 4% paraformaldehyde. Cells permeablized methanol                                           -20&#194;&#176;C 30 minutes, incubated TUNEL reaction mixture (Roche) moisture <br />                                           chamber hour 37&#194;&#176;C. Slides washed PBS, mounted mounting <br />                                           medium containing DAPI (Vectorlabs). detection cell death zebrafish hearts, hearts <br />                                           dissected zebrafish Tyrode&apos;s solution containing 3% BSA. Hearts                                           transferred microwell plate fixed 4% paraformaldehyde 20 minutes. Hearts <br />                                           rinsed PBS permeablized overnight PBS 0.1% Tween. Following <br />                                           incubation anti- Myosin Heavy Chain (MF-20) antibody overnight 4&#194;&#176;C, hearts                                           washed 3 times PBS, followed incubation secondary antibody hour NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           37&#194;&#176;C. Cell death detected using TUNEL reaction mixture (Roche) moisture <br />                                           chamber hour 37&#194;&#176;C. Hearts washed PBS placed directly                                           mounting media containing DAPI. cells hearts, images taken                                           excitation wavelengths 405 nm 555 nm, 5-7 pictures taken slides <br />                                           using LSM700 confocal microscopy (Zeiss). Percent apoptotic cell death calculated <br />                                           TUNEL positive nuclei divided total nuclei. TUNEL positive nuclei manually <br />                                           counted total nuclei counted using Image J software (NIH). counting <br />                                           performed blinded fashion. Caspase 3/7 activity determined freshly isolated <br />                                           homogenized extracts using Caspase 3/7 activity kits manufacturer&apos;s instructions <br />                                           (Promega, Caspase-Glo 3/7 Assay). Briefly, 30 &#206;&#188;g protein diluted final volume <br />                                           50 &#206;&#188;L PBS. 50 &#206;&#188;L Caspase 3/7 reaction buffer added protein sample, <br />                                           incubated 10 minutes dark, luciferase activity detected using plate <br />                                           reader (Spectra Max). <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                          Page 5 <br />  <br />  <br />                               RNA isolation quantitative PCR <br />                                           assess gene expression, total RNA isolated using Trizol (Invitrogen) extraction. <br />                                           DNAase treatment performed subsequently remove residual DNA contamination <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (Turbo DNAase, Ambion). iScript&#226;&#8222;&#162; cDNA Synthesis Kit (Bio-Rad) used                                           strand cDNA synthesis. Quantitative PCR performed using standard curve method.                                           human tissue, STC1 forward primer: ATTCCCACCAACAAAATCCA; reverse primer: <br />                                           GGAAAAACATGGCAGAGGAA. 18S forward primer: TCATGTGGTGTTGAGGAAGC; <br />                                           reverse primer: GGCGTGGATTCTGCATAATG. rat tissue, STC1 forward primer: <br />                                           CACTTCCAGATATCCGCGTT; reverse primer: CACCTGGGGTCCTTCAGATA. <br />                                           GAPDH forward primer: GGTGATGCTGGTGCTGAGTA; reverse primer: <br />                                           TTGCTGACAATCTTGAGGGA. fish tissue, STC1 forward primer: <br />                                           GTGCTTAAACAGTGCGCTC; reverse primer: GCTCCTGGGTTTGATTTGGC. EF1&#206;&#177; <br />                                           forward primer: CTGGAGGCCAGCTCAAACATGG; EF1&#206;&#177; reverse primer: <br />                                           ACTCGTGGTGCATCTCAACAGACT. <br />  <br />                               Immunohistochemistry staining <br />                                           Following cell isolation, adult cardiomyocytes cultured overnight fixed 4% <br />                                           paraformaldehyde room temperature. Cells permeabilized using 2% Triton-X100                                           glycerol/PBS (1:1 volume). Incubation 3% BSA solution 1 hour performed                                           minimize non-specific binding. Cells incubated cocktail primary <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           antibodies (anti-STC1 [1:100], COX4 [1:1000] ACTININ [1:500]) 4&#194;&#176;C 18 hours <br />                                           followed incubating secondary antibodies steps 37&#194;&#176;C.  donkey anti- <br />                                           goat Alexa Fluo 555 (1:300) used detect STC1. 1xBPS wash  goat anti- <br />                                           rabbit Alexa Fluo 488 (1:300) goat anti-mouse Alexa Fluo 647 (1:300) added <br />                                           1 hour 37&#194;&#176;C detect COX4 ACTININ, respectively. final washing,                                           slides mounted VECTASHIELD&#194;&#174; mounting media (Vector Lab). Zeiss LSM700 <br />                                           fluorescence confocal microscope used visualize STC1 (Ex/Em: 550/600 nm), COX4 <br />                                           (Ex/Em: 488/525 nm), ACTININ (Ex/Em: 648/680). DAPI used stain                                           nuclei. <br />  <br />                               Immunoblotting analysis <br />                                           cultured cardiomyocytes, protein harvested using cell lysis buffer (Cell Signaling). <br />                                           mouse heart tissue, hearts pulverized liquid nitrogen resuspended cell <br />                                           lysis buffer. zebrafish, 15-20 zebrafish suspended directly 50 &#206;&#188;L SDS loading <br />                                           buffer homogenized using tissue homogenizer (TissueLyser II, Qiagen). Following <br />                                           homogenization, samples centrifuged total protein homogenates obtained. <br />                                           30 &#206;&#188;g total protein 18 &#206;&#188;l fish protein lysate loaded Criterion XT bis-tris <br />                                           precast gels (4-12%) (Invitrogen) PAGEr Gold precast gels (4-20%) (Lonza) NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           electrophoresis. Protein electrotransferred PVDF membrane (Millipore) 30 volts <br />                                           16-18 hours 4&#194;&#176;C. blocking 5% BSA PBS, proteins detected <br />                                           incubation appropriate primary antibodies overnight 4&#194;&#176;C. washing, blots <br />                                           incubated corresponding secondary antibodies. Odyssey infrared scanner (Li-Cor) <br />                                           used determine infrared fluorescent signal GAPDH used reference <br />                                           gene normalization. <br />  <br />                               Mitochondrial membrane potential measurement <br />                                           Following STC1 (200ng/mL) vehicle administration 24 hours, cultured <br />                                           cardiomyocytes incubated cell permeable, mitochondrial membrane potential- <br />                                           sensitive fluorophore TMRE (Invitrogen) concentration 10 nM 30 minutes. <br />                                           Cardiomyocytes washed warm PBS 2 times. TMRE fluorescence  <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                              Page 6 <br />  <br />  <br />                                           measured using SpectraMax M5 Microplate Reader (Molecular Device) excitation <br />                                           wavelength 555 nm. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Mitochondrial calcium measurement <br />                                           Following 24 hour exposure STC1 (200ng/mL) vehicle, cultured neonatal <br />                                           cardiomyocytes incubated cell permeable, mitochondrial specific calcium <br />                                           fluorophore Rhod-2 [6] (Invitrogen) concentration 40 &#206;&#188;M 30 minutes 37&#194;&#176;C. <br />                                           Rhod-2 reduced colorless dye using sodium borate. Hoechst dye (40 &#206;&#188;M)                                           Mitotracker Green (250 nM) used visualize nuclei mitochondria, <br />                                           respectively. Cardiomyocytes washed twice warm PBS. Cell images                                           acquired using LSM700 confocal microscopy. specifically analyze mitochondrial <br />                                           calcium, Rhod-2 signal localized Mitotracker Green quantified. Analysis <br />                                           performed using Cell Profiler software. biological replicate, 80-100 cells                                           analyzed condition. Data averaged total 3 biological replicates. <br />  <br />                               ROS measurement <br />                                           Following STC1 (200ng/mL) vehicle administration 24 hours, cultured <br />                                           cardiomyocytes incubated cell permeable, redox-sensitive fluorophore DCFDA <br />                                           (Invitrogen) concentration 20 &#206;&#188;M 30 minutes. Cardiomyocytes                                           washed warm PBS 2 times. Cell images acquired using LSM700 confocal <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           microscopy (excitation wavelength 488nm) analyzed SigmaScan Pro.                                           determination mitochondrial-derived ROS, Mitotempo (Santa Cruz Biotech),                                           mitochondrial specific ROS scavenger, used pre-treat cardiomyocytes                                           concentration 100 nM 45 minutes prior STC1 administration. <br />  <br />                               Assessment cardiac function zebrafish <br />                                           Individual fish embryos 3 4 dpf (days post fertilization) transiently anesthetized                                           Tricaine methanesulfonate (Sigma) solution E3 embryo water. Fish embryos                                           positioned laterally image acquisition [35]. Axioplan (Zeiss) upright microscopy <br />                                           equipped FastCam-PCI high-speed camera (Photron) used image acquisition. <br />                                           Sequential images heart contraction acquired 250 frames second. 8-10 cardiac <br />                                           cycles recorded fish. Long short axes diastole systole                                           obtained using Image J (NIH) tracing cardiac cycles. Ventricular volume                                           calculated using equation Ventricular volume= (4/3) &#207;&#8364; / s2 stroke volume                                           calculated based change diastole systole. 10-12 fish examined                                           condition. <br />  <br />                               Transient STC1 overexpression zebrafish model <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Plasmid containing length zebrafish STC1 purchased Open Biosystems <br />                                           (MDR1734-99237559). mMESSAGE mMACHINE Kit (Invitrogen) used synthesize <br />                                           zebrafish STC1 mRNA. STC1 mRNA reverse order synthesized control.                                           quality/quantity mRNA determined Nanodrop spectrometer (Thermo Scientific). <br />                                           20 pg mRNA injected zebrafish embryos single cell stage. Cardiac function <br />                                           measured high-speed video camera 3 dpf (days post fertilization) cardiac cell <br />                                           death cardiac morphology determined 4dpf. <br />  <br />                               STC1 morpholino knockdown zebrafish model AL-LC cardiac toxicity <br />                                           Morpholinos (Gene-Tools, LLC) designed target boundary region exon <br />                                           2 intron 2 fish STC1 mRNA. Sequence used construct development                                           GCCTTGCCCTGTAAAATCAACAGAA. Morpholinos resuspended 1X Danieau&apos;s <br />                                           buffer (58 mmol/L NaCl, 0.7 mmol/L KCl, 0.4 mmol/L MgSO4, 0.6 mmol/L Ca(NO3)2, 0.5 <br />  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                            Page 7 <br />  <br />  <br />                                            mmol/L Hepes, pH 7.6) achieve final concentration 500 &#206;&#188;mol/L. single cell <br />                                            stage, 1 nL morpholino control (Danieau&apos;s buffer) solution injected. Veh (E3 <br />                                            water) AL-LC (1 nL 1 mg/mL) delivered circulation 2 dpf anaesthetized <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            control STC1 MO injected embryos venous injection described previously [29]. <br />                                            Cardiac function assessed using high-speed camera, described  days post <br />                                            LC injections (4dpf). days following LC delivery (5dpf), protein expression cell <br />                                            death determined using immunoblotting STC1 TUNEL staining, respectively. <br />                                            addition, zebrafish survival determined hearts embryos harvested                                            TUNEL staining immunoblotting, respectively. Zebrafish survival measured                                            counting zebrafish number STC1 MO control injected embryos immediately (2dpf) <br />                                            3 days (5dpf) following AL-LC vehicle injection percent survival                                            calculated accordingly. percent survival averaged 5 independent repeats. <br />  <br />                               Statistical analysis <br />                                            data shown mean &#194;&#177; standard error. Statistical differences mean values                                            groups evaluated Student t test using GraphPad Prism software. Statistical <br />                                            differences mean values multiple groups evaluated way analysis                                            variance. comparisons significant, post-hoc Bonferroni&apos;s test used                                            compare individual groups. p&lt;0.05 considered significant. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Results <br />                               STC1 upregulated patients AL amyloid cardiomyopathy response                               human AL-LC <br />                                            validate microarray gene profiling data (del Monte laboratory unpublished data), human <br />                                            heart samples (left ventricle) obtained AL amyloid cardiomyopathy patients <br />                                            (n=6) control patients heart disease (n=5) collected cold oxygenated Wisconsin <br />                                            cardioplegic solution immediately following harvest. STC1 mRNA expression                                            quantified using real-time PCR, upregulated hearts patients AL <br />                                            amyloid cardiomyopathy relative control non-failing heart samples (Fig. 1a). STC1 <br />                                            protein expression quantified immunoblotting analysis human heart samples,                                            similarly selectively upregulated patients AL amyloid cardiomyopathy <br />                                            (Fig. 1b). determine STC1 expression induced AL-LC proteins absence <br />                                            fibril formation, adult rat ventricular cardiomyocytes exposed human AL- <br />                                            LC (20 &#206;&#188;g/mL), LC (20 &#206;&#188;g/mL), vehicle control. AL-LC LC vehicle, <br />                                            induced STC1 mRNA expression hour (Fig 1c), subsequent increases                                            STC1 protein expression early (2 hours) late (24 hours) time points (Fig 1d, e). <br />                                            Importantly, upregulation STC1 protein expression observed response AL-LC <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            proteins isolated 5 different AL amyloidosis patients (Fig. 1f). data demonstrate <br />                                            STC1 expression specifically upregulated AL-LC proteins patients                                            AL amyloid cardiomyopathy isolated cardiomyocytes. <br />  <br />                               AL-LC induces STC1 upregulation p38MAPK dependent manner <br />                                            Previously, shown p38MAPK activation occurs minutes AL-LC <br />                                            exposure required AL-LC induced cardiotoxicity [34]. determine                                            p38MAPK regulates STC1 induction, isolated cardiomyocytes treated AL-LC, <br />                                            LC, vehicle presence absence SB203580, selective p38MAPK inhibitor <br />                                            [34]. Inhibition p38MAPK completely prevented STC1 upregulation response AL- <br />                                            LC (Fig. 2a). established mouse model AL-LC cardiotoxicity, generated                                            parenteral injection AL-LC proteins [34], human AL-LC induced cardiac STC1 protein <br />                                            expression mice, compared LC treated mice (Fig. 2b). AL-LC induction cardiac <br />                                            STC1 expression,  abolished transgenic mice cardiac expression  <br />                                             Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                          Page 8 <br />  <br />  <br />                                           dominant negative p38MAPK (DN-TG) (Fig. 2b). Collectively, vitro vivo <br />                                           data demonstrate AL-LC induction STC1 downstream p38MAPK activation,                                           necessary early signaling event upstream AL-LC induced cardiac toxicity. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               STC1 induces mitochondrial dysfunction provokes ROS generation <br />                                           investigate function STC1 cardiomyocytes, sought delineate                                           cellular location STC1. Using immunohistochemical staining, STC1                                           expressed nuclei mitochondria (Fig. 3a). Mitochondrial localization                                           confirmed staining STC1 mitochondrial protein, COX4, shown                                           Fig. 3b Fig. 3c. Given mitochondrial localization, examined STC1 <br />                                           alters mitochondrial function measuring mitochondrial membrane potential using                                           cell-permeable mitochondrial membrane potential-sensitive dye tetramethylrhodamine, ethyl <br />                                           ester (TMRE). data showed STC1 treatment significantly reduced mitochondrial <br />                                           membrane potential (Fig. 3d).  STC1 induced ROS production                                           attenuated pretreatment MitoTempo, mitochondrial specific ROS scavenger <br />                                           (Fig. 3e, f). determine STC1 affects cardiomyocyte mitochondrial calcium <br />                                           levels, mitochondrial calcium concentration measured using mitochondrial calcium <br />                                           probe, Rhod2. STC1 significantly elevates mitochondrial calcium levels (Fig <br />                                           3g, h), suggesting role STC1 dysregulation calcium homeostasis                                           mitochondrial function. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               STC1 recapitulates AL-LC cardiac pathology vitro vivo <br />                                           define effects STC1 upregulation cardiomyocytes, STC1 overexpressed                                           adenoviral mediated gene transfer isolated adult rat cardiomyocytes. Expression STC1 <br />                                           (Adeno-STC1) control GFP (Adeno-GFP) titrated levels comparable                                           induced human AL-LC exposure, &#226;&#710;&#188;1.5-2 fold increase (Fig. S1), avoid non-specific <br />                                           toxic effects associated excessive protein expression. STC1 overexpression decreased <br />                                           cell shortening (Fig 4a) diminished calcium transient amplitude (Fig 4b) concomitantly, <br />                                           measured single cardiomyocytes using video edge detection techniques                                           fluorescent calcium sensitive dye. Furthermore, STC1 overexpression increased cell death, <br />                                           assessed Bax/Bcl-2 ratio (Fig. 4c) quantification TUNEL positive cells (Fig. <br />                                           4d). summary, STC1 overexpression caused cardiomyocyte dysfunction cell death, <br />                                           recapitulating AL-LC induced cardiac toxicity cardiomyocytes [34]. <br />  <br />                                           determine STC1 adversely affects cardiac function cell viability vivo, <br />                                           STC1 transiently overexpressed zebrafish delivery STC1 mRNA  <br />                                           cell stage development followed measurement cardiac function, TUNEL assay                                           morphological assessment illustrated Fig. 5a. size purity mRNA NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           confirmed showed Fig. S2a. STC1 mRNA (Fig. 5b) protein expression levels (Fig. <br />                                           5c) confirmed upregulated zebrafish 4dpf (4 days following STC1 mRNA <br />                                           injection). Equal protein loading confirmed Ponceau staining (Fig. S2b). Using <br />                                           high-speed camera imaging, reduction stroke volume (Fig. 5d) cardiac output (Fig. <br />                                           5e) observed early 3 days post STC1 mRNA injection (3dpf). difference                                           heart rate STC1 overexpressing fish controls (Fig. 5f). Strikingly, <br />                                           STC1-overexpressing zebrafish displayed pericardial edema, characteristic landmark <br />                                           cardiac dysfunction zebrafish (Fig. 5g). Additionally, observed increased cardiac <br />                                           cell death cardiomyocytes STC1-overexpressing zebrafish compared controls,                                           assessed TUNEL cardiac marker (MF20) staining isolated hearts 4 dpf (Fig. <br />                                           5h, . similar increase cardiac cell death observed STC1-overexpressing <br />                                           zebrafish 5 dpf, compared controls (Fig. S3a, b). accordance                                           phenotype observed STC1 overexpressing zebrafish, transient overexpression                                           STC1 mouse hearts vivo adenoviral-mediated gene transfer (Fig. S4a) resulted  <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                             Page 9 <br />  <br />  <br />                                           similar depression cardiac function (Fig. S4b). Additionally, cardiac cell death                                           increased STC1-overexpressing mouse hearts, assessed increased Bax/Bcl-2 ratio (Fig. <br />                                           S4c) caspase 3/7 activity (Fig. S4d). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               STC1 required AL-LC induced cardiac toxicity vitro vivo <br />                                           determine STC1 plays causal role AL-LC induced cardiomyocyte <br />                                           dysfunction death, STC1 expression genetically silenced using adenoviral-mediated <br />                                           expression shRNA targeting STC1 (Adeno-STC1-shRNA) adult cardiomyocytes. <br />                                           Adeno-STC1-shRNA attenuated STC1 expression induced AL-LC adult <br />                                           cardiomyocytes compared scrambled controls (Fig. 6a), prevented AL-LC induced <br />                                           contractile dysfunction (Fig. 6b) impaired calcium homeostasis (Fig. 6c). AL-LC- <br />                                           induced cell death attenuated Adeno-STC1-shRNA treated cardiomyocytes (Fig. 6d). <br />                                           data demonstrate requirement STC1 mediating AL-LC induced cellular <br />                                           dysfunction death. <br />  <br />                                           necessity STC1 mediating AL-LC induced cardiac dysfunction mortality                                           examined vivo using zebrafish model AL-LC toxicity [29]. Consistent vitro <br />                                           experiments, injection human AL-LC induced STC1 expression (Fig. 7a). time <br />                                           course morpholino injection various functional morphological readouts                                           outlined Fig. 7b. Similar vitro observations, AL-LC injection decreased cardiac <br />                                           function (Fig. 7c, d) increased cardiac cell death (Fig. 7e, f) increased <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mortality (Fig. 7g), prevented STC1 morphants (Fig. 7c-g). notable <br />                                           morpholino mediated knockdown successfully attenuated AL-LC induced STC1 <br />                                           upregulation entire time frame study showed Fig. 7h. Collectively,                                           results established STC1 critical mediator AL-LC induced cardiac pathology <br />                                           suggest antagonism STC1 serve novel therapeutic treatment approach. <br />  <br />                               Discussion <br />                                           common forms cardiomyopathy, prevalence AL <br />                                           cardiomyopathy comparable Hodgkin&apos;s lymphoma chronic myelogenous <br />                                           leukemia [11]. Importantly, current statistics provide underestimation                                           prevalence AL cardiomyopathy diagnosis resulting insidious onset                                           disease, rapid progression, insufficient clinical awareness. Unlike forms                                           cardiomyopathy, AL amyloidosis cardiomyopathy largely unresponsive standard <br />                                           treatment regimens, resulting early mortality [10]. study, provide critical <br />                                           molecular insight pathogenesis fatal disease identify STC1 key <br />                                           mediator AL-LC cardiotoxicity vitro vivo, highlighting potential                                           STC1 viable therapeutic target. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           initially hypothesized AL amyloid cardiomyopathy direct result                                           infiltrative disease process associated extracellular deposition amyloid fibrils                                           heart coupled passive restriction cardiac function.  clinical observations <br />                                           discordant proposed mechanism, little correlation degree                                           cardiac fibril infiltration cardiac dysfunction patients AL <br />                                           amyloid cardiomyopathy [8]. Instead, mortality correlate levels <br />                                           circulating LC [8].  reduction circulating AL-LC shown                                           correlative improvement cardiac performance prolonged patient survival, despite                                           persistence cardiac amyloid deposits [31]. line clinical observations,                                           laboratory subsequent independent confirmation [27, 28, 36] demonstrated <br />                                           direct cardiotoxic effect AL-LC proteins absence fibril formation, vitro <br />                                           vivo [2, 24, 34].  AL amyloidosis results intermingling pathogenic <br />                                           mechanisms involving amyloid fibril deposition direct cardiac toxicity AL-LC <br />  <br />                                            Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                          Page 10 <br />  <br />  <br />                                          precursor protein. finding activation non-canonical p38MAPK pathway                                          minutes AL-LC exposure provided evidence acute induction specific <br />                                          AL-LC mediated signaling pathways heart [34]. study, reveal STC1 NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          novel downstream molecule AL-LC mediated p38MAPK activation. Importantly,                                          STC1 expression induced AL-LC proteins isolated separate AL <br />                                          patients, non-amyloidogenic LC proteins multiple myeloma patients, <br />                                          suggesting observed STC1 upregulation potential artifact associated <br />                                          human AL-LC sample, generalizable AL amyloid <br />                                          cardiomyopathy. <br />  <br />                                          STC1 glycoprotein identified bony fish calcium regulatory hormone [38].                                          mammalian STC1 homolog shares sequence homology fish counterpart,                                          implicated multitude cellular processes, including ischemic injury, apoptosis, <br />                                          angiogenesis, inflammation, cancer biology, bone muscle development, cellular <br />                                          metabolism, calcium regulation, differentiation endothelial permeability [4, 9, 12, 17, <br />                                          18, 20, 30, 33, 38-40, 42, 44, 45]. Numerous reports shown role STC1                                          mediator apoptosis [20, 22, 42], demonstrating pro-apoptotic anti-apoptotic roles <br />                                          depending cell type stimulus. recent report Nguyen et al suggested                                          pathologic role STC1 promoting apoptosis conditions oxidative stress [30]. <br />                                          Additionally, STC1 identified mediator apoptotic cell death                                          amyloidogenic A&#206;&#178; protein-treated endothelial cells radiated fibroblasts [1, 23]. NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          study suggests critical role STC1 extending localized amyloidosis, systemic <br />                                          amyloid diseases, specifically AL amyloid cardiomyopathy. Importantly, cardiac STC1 <br />                                          expression differentially increased patients AL amyloid cardiomyopathy                                          idiopathic dilated cardiomyopathy (del Monte Laboratory unpublished data). able <br />                                          simulate increased STC1 observed AL cardiomyopathy patients fish, mouse                                          isolated rat cardiomyocytes, exposure human AL-LC, suggesting upregulation <br />                                          STC1 occurs cardiomyocyte autonomous process independent cardiac endothelial <br />                                          fibroblast cells (Fig. S5).  STC1 activation highly dependent                                          p38MAPK activation, determined vitro pharmacologic inhibition vivo <br />                                          using mice overexpressing dominant negative p38MAPK. <br />  <br />                                          profound diastolic dysfunction extensive amyloid fibril deposition                                          predominant manifestation AL cardiomyopathy, systolic dysfunction present.                                          degree systolic dysfunction actually underestimated using traditional <br />                                          echocardiographic parameters ejection fraction, recently detected using <br />                                          sensitive approaches including strain analysis [19]. isolated cardiomyocytes, <br />                                          exposure AL-LC markedly decreases contractile dysfunction observed similar <br />                                          impairment systolic function vivo zebrafish exposed AL-LC, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          overexpressing STC1. <br />  <br />                                          report demonstrate pathological role cardiac STC1 AL-LC induced <br />                                          cardiac toxicity. adverse effect STC1 heart consistent reports <br />                                          suggesting STC1 promotes cell death multiple cell types response diverse stress <br />                                          signals. STC1 act negative regulator fibroblast cell survival conditions                                          oxidative stress [30]. STC1 reported induced mRNA protein <br />                                          levels <span id='am-21' about='obo:IMR_0200487' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-22' property="rdfs:label" content="H2O2" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:id" content="IMR:0200487" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasDbXref" content="KEGG:C00027" datatype="xsd:string"></span>H2O2</span> furthermore, STC1 null mouse embryonic fibroblasts resistant                                          growth inhibition cell death induced H2O2 20% <span id='am-26' about='obo:IMR_0200217' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-27' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:id" content="IMR:0200217" datatype="xsd:string"></span><span id='am-29' property="rdfs:label" content="O2" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00007" datatype="xsd:string"></span>O2</span>. Reintroduction STC1                                          null mouse embryonic fibroblasts increases cell death conditions oxidative stress <br />                                          [30]. contrast, cell types, neurons mesenchymal stem cells, STC1                                          suggested exert protective functions [1, 45]. vivo data showing deleterious <br />                                          effects STC1 supported independent STC1 transgenic mouse studies                                          STC1 overexpression results decreased muscle mass deterioration muscle function <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                        Page 11 <br />  <br />  <br />                                          [12, 37]. STC1&apos;s role highly context dependent, genetic ablation STC1 mice <br />                                          associated little basal phenotype [3], highlighting potential                                          targeted STC1 antagonism therapeutic strategy. data STC1 mediated <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          mitochondrial damage, potentially calcium overload, resulting ROS production                                          loss mitochondrial integrity, underlying mechanism STC1-induced cardiac <br />                                          toxicity. Consistent findings, using cellular models STC1 transgenic mice, <br />                                          reports indicated STC1 directly targets mitochondria, causing profound <br />                                          dysfunction deformation mitochondria [9, 12]. Relevant finding, recent studies <br />                                          shown STC1 impair mitochondrial calcium homeostasis [9]. observed <br />                                          increased mitochondria calcium response STC1   contribute decrease <br />                                          cytosolic calcium concentration. Altered cytosolic mitochondrial calcium levels                                          result impaired contractile function elevated ROS / mitochondrial dysfunction, <br />                                          respectively. Antagonizing STC1 resulted beneficial effects vitro vivo,                                          isolated cardiomyocytes zebrafish, respectively.  remains determined <br />                                          antagonizing STC1 alters natural progression amyloid cardiomyopathy                                          animal models, including involving chronic exposure AL-LC,                                          antagonizing STC1 viable option treatment amyloid cardiomyopathy <br />                                          patients. <br />  <br />                                          current lack understanding molecular mechanisms underlying AL amyloid <br />                                          cardiomyopathy critical bottleneck development treatment diagnostics NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          disease. work presented represents efforts understanding                                          mechanisms underlying fatal disease demonstrate critical role STC1 <br />                                          mediating AL-LC induced proteotoxicity vitro vivo, studies                                          animal models patients, required definitively define pathophysiologic <br />                                          basis amyloid cardiomyopathy role STC1 process. <br />  <br />                               Supplementary Material <br />                                          Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                          authors thank Ms. Wendy Du Carnegie Mellon University, Mr. Soeun Ngoy Brigham Women&apos;s <br />                                          Hospital (BWH) Cardiovascular Physiology Core, Ms. Gloria Chan Boston University (BU) Amyloidosis Center <br />                                          excellent technical assistances Drs. Yingyi Zhang, Judith Gwathmey Thomas E. Macgillivray                                          providing critical reagents. work supported,  National Institutes Health (NIH), <br />                                          HL088533, HL086967, HL093148, HL099073 (R.L.), DK90696 (D.C.S.), AG031804 (L.H.C.), American Heart <br />                                          Association (C M.), Cardiac Amyloid Center, BWH (R.H.F., R.L.) Gruss Wildflower <br />                                          Foundations Amyloid Research Fund BU (L.H.C., D.C.S.). G.M. supported Associazione Italiana <br />                                          la Ricercasul Cancro Special Program 5x mille, Molecular Clinical Oncology. S.M. supported NIH T32 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          (T32HL007604). <br />  <br />  <br />                               References <br />                                          1. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, Dimattia G, Sullivan  <br />                                             Prockop DJ. Multipotent stromal cells activated reduce apoptosis upregulation                                             secretion stanniocalcin-1. Stem Cells. 2009; 27:670&#226;&#8364;&#8220;681.10.1002/stem.20080742 [PubMed: <br />                                             19267325] <br />                                          2. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R. Human <br />                                             amyloidogenic light chains directly impair cardiomyocyte function increase cellular <br />                                             oxidant stress. Circ Res. 2004; 94:1008&#226;&#8364;&#8220;1010.10.1161/01.RES.0000126569.75419.74 [PubMed: <br />                                             15044325] <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                  Page 12 <br />  <br />  <br />                                          3. Chang AC, Cha J, Koentgen F, Reddel RR. murine stanniocalcin 1 gene essential                                             growth development. Mol Cell Biol. 2005; 25:10604&#226;&#8364;&#8220;10610.10.1128/MCB. <br />                                             25.23.10604-10610.2005 [PubMed: 16287871] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          4. Chang AC, Jellinek DA, Reddel RR. Mammalian stanniocalcins cancer. Endocr Relat Cancer. <br />                                             2003; 10:359&#226;&#8364;&#8220;373.10.1677/erc.0.0100359 [PubMed: 14503913] <br />                                          5. Connors LH, Jiang Y, Budnik M, Theberge R, Prokaeva T, Bodi KL, Seldin DC, Costello CE, <br />                                             Skinner M. Heterogeneity primary structure, post-translational modifications, germline gene <br />                                             usage length amyloidogenic kappa1 immunoglobulin light chains. Biochemistry. 2007; <br />                                             46:14259&#226;&#8364;&#8220;14271.10.1021/bi7013773 [PubMed: 18004879] <br />                                          6. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado- <br />                                             Vieira R, McEwen BS, Manji HK. Dynamic regulation mitochondrial function                                             glucocorticoids. Proc Natl Acad Sci U S  2009; 106:3543&#226;&#8364;&#8220;3548.10.1073/pnas.0812671106 <br />                                             [PubMed: 19202080] <br />                                          7. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. clinical <br />                                             features immunoglobulin light-chain (AL) amyloidosis heart involvement. QJM. 1998; <br />                                             91:141&#226;&#8364;&#8220;157.10.1093/qjmed/91.2.141 [PubMed: 9578896] <br />                                          8. Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial primary (AL) cardiac <br />                                             amyloidosis: echocardiographically similar diseases distinctly different clinical outcomes. <br />                                             Heart. 1997; 78:74&#226;&#8364;&#8220;82.10.1136/hrt.78.1.74 [PubMed: 9290406] <br />                                          9. Ellard JP, McCudden CR, Tanega C, James KA, Ratkovic S, Staples JF, Wagner GF.                                             respiratory effects stanniocalcin-1 (STC-1) intact mitochondria cells: STC-1 uncouples <br />                                             oxidative phosphorylation actions modulated <span id='am-13' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-20' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span>nucleotide</span> triphosphates. Mol Cell <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Endocrinol. 2007; 264:90&#226;&#8364;&#8220;101.10.1016/j.mce.2006.10.008 [PubMed: 17092635] <br />                                          10. Falk RH. Cardiac amyloidosis: treatable disease, overlooked. Circulation. 2011; 124:1079&#226;&#8364;&#8220; <br />                                               1085.10.1161/CIRCULATIONAHA.110.010447 [PubMed: 21875922] <br />                                          11. Falk RH. Diagnosis management cardiac amyloidoses. Circulation. 2005; 112:2047&#226;&#8364;&#8220; <br />                                               2060.10.1161/CIRCULATIONAHA.104.489187 [PubMed: 16186440] <br />                                          12. Filvaroff EH, Guillet S, Zlot C, Bao M, Ingle G, Steinmetz H, Hoeffel J, Bunting S, Ross J, Carano <br />                                               RA, Powell-Braxton L, Wagner GF, Eckert R, Gerritsen  French DM. Stanniocalcin 1 alters <br />                                               muscle bone structure function transgenic mice. Endocrinology. 2002; 143:3681&#226;&#8364;&#8220; <br />                                               3690.10.1210 2001-211424 [PubMed: 12193584] <br />                                          13. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, Cui L, Kumar  Lin  Sen- <br />                                               Banerjee S, Das H, Petersen CA, Mende U, Burleigh BA, Zhu Y, Pinto YM, Liao R, Jain MK. <br />                                               Kruppel-like factor 15 regulator cardiomyocyte hypertrophy. Proc Natl Acad Sci U S  <br />                                               2007; 104:7074&#226;&#8364;&#8220;7079.10.1073/pnas.0701981104 [PubMed: 17438289] <br />                                          14. Guan J, Mishra S, Falk RH, Liao R. Current perspectives cardiac amyloidosis. J Physiol <br />                                               Heart Circ Physiol. 2012; 302:H544&#226;&#8364;&#8220;552.10.1152/ajpheart.00815.2011 [PubMed: 22058156] <br />                                          15. Ishibashi K, Imai M. Prospect stanniocalcin endocrine/paracrine mammals. J <br />                                               Physiol Renal Physiol. 2002; 282:F367&#226;&#8364;&#8220;375.10.1152/ajprenal.00364.2000 [PubMed: 11832417] <br />                                          16. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Handy  Loscalzo J, Apstein CS, Liao R. Glucose-6-phosphate dehydrogenase modulates <br />                                               cytosolic redox status contractile phenotype adult cardiomyocytes. Circ Res. 2003; 93:e9&#226;&#8364;&#8220; <br />                                               16.10.1161/01.RES.0000083489.83704.76 [PubMed: 12829617] <br />                                          17. Kanellis J, Bick R, Garcia G, Truong L, Tsao CC, Etemadmoghadam D, Poindexter B, Feng L, <br />                                               Johnson RJ, Sheikh-Hamad D. Stanniocalcin-1, inhibitor macrophage chemotaxis                                               chemokinesis. J Physiol Renal Physiol. 2004; 286:F356&#226;&#8364;&#8220;362.10.1152/ajprenal.00138.2003 <br />                                               [PubMed: 14570698] <br />                                          18. Koizumi K, Hoshiai M, Ishida H, Ohyama K, Sugiyama H, Naito  Toda T, Nakazawa H, <br />                                               Nakazawa S. Stanniocalcin 1 prevents cytosolic Ca2+ overload cell hypercontracture                                               cardiomyocytes. Circ J. 2007; 71:796&#226;&#8364;&#8220;801.10.1253/circj.71.796 [PubMed: 17457011] <br />                                          19. Koyama J, Falk RH. Prognostic significance strain Doppler imaging light-chain amyloidosis. <br />                                               JACC Cardiovasc Imaging. 2010; 3:333&#226;&#8364;&#8220;342.10.1016/j.jcmg.2009.11.013 [PubMed: 20394893] <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                Page 13 <br />  <br />  <br />                                          20. Lai KP, Law AY, Yeung HY, Lee LS, Wagner GF, Wong CK. Induction stanniocalcin-1 <br />                                              expression apoptotic human nasopharyngeal cancer cells p53. Biochem Biophys Res <br />                                              Commun. 2007; 356:968&#226;&#8364;&#8220;975.10.1016/j.bbrc.2007.03.074 [PubMed: 17395153] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          21. Law AY, Ching LY, Lai KP, Wong CK. Identification characterization hypoxia- <br />                                              responsive element human stanniocalcin-1 gene. Mol Cell Endocrinol. 2010; 314:118&#226;&#8364;&#8220; <br />                                              127.10.1016/j.mce.2009.07.007 [PubMed: 19628018] <br />                                          22. Law AY, Lai KP, Lui WC, Wan HT, Wong CK. Histone deacetylase inhibitor-induced cellular <br />                                              apoptosis involves stanniocalcin-1 activation. Exp Cell Res. 2008; 314:2975&#226;&#8364;&#8220;2984.10.1016/ <br />                                              j.yexcr.2008.07.002 [PubMed: 18652825] <br />                                          23. Li K, Dong D, Yao L, Dai D, Gu X, Guo L. Identification STC1 beta-amyloid activated <br />                                              gene human brain microvascular endothelial cells using cDNA microarray. Biochem Biophys <br />                                              Res Commun. 2008; 376:399&#226;&#8364;&#8220;403.10.1016/j.bbrc.2008.08.158 [PubMed: 18786506] <br />                                          24. Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, Falk RH, Apstein CS. Infusion light <br />                                              chains patients cardiac amyloidosis causes diastolic dysfunction isolated mouse <br />                                              hearts. Circulation. 2001; 104:1594&#226;&#8364;&#8220;1597. [PubMed: 11581134] <br />                                          25. Merlini G, Bellotti V. Molecular mechanisms amyloidosis. N Engl J Med. 2003; 349:583&#226;&#8364;&#8220; <br />                                              596.10.1056/NEJMra023144 [PubMed: 12904524] <br />                                          26. Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis new therapeutic options. J Clin <br />                                              Oncol. 2011; 29:1924&#226;&#8364;&#8220;1933.10.1200/JCO.2010.32.2271 [PubMed: 21483018] <br />                                          27. Migrino RQ, Hari P, Gutterman DD, Bright M, Truran S, Schlundt B, Phillips SA. Systemic                                              microvascular oxidative stress induced light chain amyloidosis. Int J Cardiol. 2010; 145:67&#226;&#8364;&#8220; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              68.10.1016/j.ijcard.2009.04.044 [PubMed: 19446898] <br />                                          28. Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B, Timmons M, Motta  <br />                                              Phillips SA, Hari P. Human microvascular dysfunction apoptotic injury induced AL <br />                                              amyloidosis light chain proteins. J Physiol Heart Circ Physiol. 2011; 301:H2305&#226;&#8364;&#8220; <br />                                              2312.10.1152/ajpheart.00503.2011 [PubMed: 21963839] <br />                                          29. Mishra S, Guan J, Plovie E, Seldin DC, Connors LH, Merlini G, Falk RH, Macrae CA, Liao R. <br />                                              Human amyloidogenic light chain proteins result cardiac dysfunction, cell death early <br />                                              mortality zebrafish. J Physiol Heart Circ Physiol. 2013; 305:H95&#226;&#8364;&#8220;H103.10.1152/ajpheart. <br />                                              00186.2013 [PubMed: 23624626] <br />                                          30. Nguyen  Chang AC, Reddel RR. Stanniocalcin-1 acts negative feedback loop                                              prosurvival ERK1/2 signaling pathway oxidative stress. Oncogene. 2009; 28:1982&#226;&#8364;&#8220; <br />                                              1992.10.1038/onc.2009.65 [PubMed: 19347030] <br />                                          31. Palladini G, Lavatelli F, Russo P, Perlini S, Perfetti V, Bosoni T, Obici L, Bradwell AR, D&apos;Eril <br />                                              GM, Fogari R, Moratti R, Merlini G. Circulating amyloidogenic free light chains serum N- <br />                                              terminal natriuretic <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-4' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-5' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span>peptide</span> type B decrease simultaneously association improvement                                              survival AL. Blood. 2006; 107:3854&#226;&#8364;&#8220;3858.10.1182/blood-2005-11-4385 [PubMed: 16434487] <br />                                          32. Panakova D, Werdich AA, Macrae CA. Wnt11 patterns myocardial electrical gradient                                              regulation L-type Ca(2+) channel. Nature. 2010; 466:874&#226;&#8364;&#8220;878.10.1038/nature09249 <br />                                              [PubMed: 20657579] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          33. Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, Poindexter B, Taegtmeyer H, <br />                                              Wamsley  Padda R, Entman M, Nielsen S, Youker K. Stanniocalcin-1 naturally occurring L- <br />                                              channel inhibitor cardiomyocytes: relevance human heart failure. J Physiol Heart Circ <br />                                              Physiol. 2003; 285:H442&#226;&#8364;&#8220;448.10.1152/ajpheart.01071.2002 [PubMed: 12663264] <br />                                          34. Shi J, Guan J, Jiang B, Brenner DA, Del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran <br />                                              MJ, Macgillivray TE, Seldin DC, Falk R, Liao R. Amyloidogenic light chains induce <br />                                              cardiomyocyte contractile dysfunction apoptosis non-canonical p38alpha MAPK <br />                                              pathway. Proc Natl Acad Sci U S  2010; 107:4188&#226;&#8364;&#8220;4193.10.1073/pnas.0912263107 [PubMed: <br />                                              20150510] <br />                                          35. Shin JT, Pomerantsev EV, Mably JD, MacRae CA. High-resolution cardiovascular function <br />                                              confirms functional orthology myocardial contractility pathways zebrafish. Physiol <br />                                              Genomics. 2010; 42:300&#226;&#8364;&#8220;309.10.1152/physiolgenomics.00206.2009 [PubMed: 20388839] <br />                                          36. Sikkink LA, Ramirez-Alvarado M. Cytotoxicity amyloidogenic immunoglobulin light chains                                              cell culture. Cell Death Dis. 2010; 1:e98.10.1038/cddis.2010.75 [PubMed: 21368874] <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                                  Page 14 <br />  <br />  <br />                                          37. Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE. Overexpression                                              human stanniocalcin affects growth reproduction transgenic mice. Endocrinology. 2002; <br />                                              143:868&#226;&#8364;&#8220;876.10.1210 143.3.868 [PubMed: 11861508] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          38. Wagner GF, Dimattia GE. stanniocalcin family proteins. J Exp Zoolog Comp Exp Biol. <br />                                              2006; 305:769&#226;&#8364;&#8220;780.10.1002/jez 313 <br />                                          39. Wang Y, Huang L, Abdelrahim M, Cai Q, Truong  Bick R, Poindexter B, Sheikh-Hamad D. <br />                                              Stanniocalcin-1 suppresses superoxide generation macrophages induction                                              mitochondrial UCP2. J Leukoc Biol. 2009; 86:981&#226;&#8364;&#8220;988.10.1189/jlb.0708454 [PubMed: 19602668] <br />                                          40. Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson LC. Hypoxic <br />                                              preconditioning induces neuroprotective stanniocalcin-1 brain 6 signaling. Stroke. 2007; <br />                                              38:1025&#226;&#8364;&#8220;1030.10.1161/01.STR.0000258113.67252.fa [PubMed: 17272771] <br />                                          41. Westerfield, M. zebrafish book. guide laboratory use zebrafish (Danio rerio). <br />                                              University Oregon Press; Eugene: 2000. <br />                                          42. Wu S, Yoshiko Y, Luca F. Stanniocalcin 1 acts paracrine regulator growth plate <br />                                              chondrogenesis. J Biol Chem. 2006; 281:5120&#226;&#8364;&#8220;5127.10.1074/jbc.M506667200 [PubMed: <br />                                              16377640] <br />                                          43. Yankner BA, Lu T. Amyloid beta-protein toxicity pathogenesis Alzheimer disease. J <br />                                              Biol Chem. 2009; 284:4755&#226;&#8364;&#8220;4759.10.1074/jbc.R800018200 [PubMed: 18957434] <br />                                          44. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, Wong CK. Hypoxia-inducible factor-1- <br />                                              mediated activation stanniocalcin-1 human cancer cells. Endocrinology. 2005; 146:4951&#226;&#8364;&#8220; <br />                                              4960.10.1210 2005-0365 [PubMed: 16109785] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          45. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC. Stanniocalcin:                                              molecular guard neurons cerebral ischemia. Proc Natl Acad Sci U S  2000; 97:3637&#226;&#8364;&#8220; <br />                                              3642.10.1073/pnas.070045897 [PubMed: 10725397] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                        Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 1. <br />                                          STC1 upregulated patients AL cardiomyopathy response AL-LC <br />                                          stimulation. STC1 gene expression (normalized 18S) b STC1 protein expression <br />                                          relative GAPDH upregulated AL cardiomyopathy patients (N=6) compared                                          non-failing control patients (N=5). AL-LC triggers c STC1 gene d, e protein expression <br />                                          isolated cardiomyocytes exposed AL-LC 2 hour 24 hours, respectively, relative <br />                                          exposed LC Veh. f STC1 upregulated early AL-LC obtained <br />                                          5 independent patients amyloid cardiomyopathy compared Veh LC. <br />                                          * p&lt;0.05 indicated groups. <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                      Page 16 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 2. <br />                                          AL-LC induction STC1 p38MAPK dependent vitro vivo. AL-LC induced <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          upregulation STC1 protein expression cardiomyocytes abolished presence                                          p38MAPK inhibitor, SB203580 (5 &#206;&#188;mol/L). b AL-LC triggered upregulation cardiac <br />                                          STC1 protein expression prevented p38MAPK dominate negative (DN-TG) mice. * <br />                                          p&lt;0.05, AL-LC vs. vehicle LC, # p&lt;0.05 AL-LC vs. SB203580 AL- <br />                                          LC infused wild type mice vs. DN-TG mice. N=3 group. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                      Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 3. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          STC1 affects mitochondrial calcium homeostasis function. Subcellular localization                                          STC1 cardiomyocytes determined using immunohistochemical staining DAPI <br />                                          (blue), STC1 (red), mitochondrial COX4 (green), myofilament protein, ACTININ <br />                                          (white). b Merged images immunohistochemical staining indicates STC1  <br />                                          localized mitochondria nucleus. c Line scanning analysis demonstrates close <br />                                          overlap spectral profiles red fluorophore (STC1) green fluorophore (COX4), <br />                                          confirming mitochondrial localization STC1. d Mitochondrial membrane potential                                          decreased cardiomyocytes exposed 200 ng/mL STC1 24 hours determined                                          TMRE, mitochondrial membrane potential sensitive fluorescence dye. e AL-LC induced <br />                                          ROS prevented cardiomyocytes treated mitochondrial targeted ROS <br />                                          scavenger, MitoTempo. f Representative DCFDA fluorescence images corresponding <br />                                          bright field images right. g Representative fluorescent images Rhod2 (red)                                          mitotracker (green), suggesting increased mitochondrial calcium response 200 ng/mL <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                         Page 18 <br />  <br />  <br />                                          STC1 stimulation 24 hours. h Summarized data mitochondrial calcium levels. * <br />                                          p&lt;0.05 indicated groups. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Basic Res Cardiol. Author manuscript; available PMC 2014 September 01. <br />                             Guan et al.                                                                                         Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Fig. 4. <br />                                  <br /> </body></html>